B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection

With the goal to design effective HIV vaccines, intensive studies focused on broadly neutralizing antibodies, which arise in a fraction of HIV-infected people. Apart from identifying new vulnerability sites in the viral envelope proteins, these studies have shown that a fraction of these antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Borhis, Gwenoline, Trovato, Maria, Chaoul, Nada, Ibrahim, Hany M., Richard, Yolande
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663724/
https://www.ncbi.nlm.nih.gov/pubmed/29163465
http://dx.doi.org/10.3389/fimmu.2017.01338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663724/
https://www.ncbi.nlm.nih.gov/pubmed/29163465
http://dx.doi.org/10.3389/fimmu.2017.01338

Ejemplares similares